All In Biotech

Drug Trial Radar · NCT06290713

Vasodilator and Exercise Study for DMD (VASO-REx)

Vasodilators and Exercise as Adjuvant Therapy for Duchenne Muscular Dystrophy (VASO-REx Study)

Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Jun 5, 2024

Primary completion

Nov 2026

Study completion Nov 2026

Sponsor

Lead sponsor
University of FloridaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
First posted
Mar 4, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Examining two strategies as potential adjuvant therapies for Duchenne muscular dystrophy (DMD); aerobic exercise training (to induce adaptations in skeletal muscle and improve cardiovascular health) and tadalafil, an FDA-approved vasodilator (to optimize blood flow and muscle perfusion which is impaired and often overlooked in DMD). Target: improved muscle function, vascular health, and DMD treatment.

Conditions

  • Duchenne Muscular Dystrophy
  • Duchenne Disease
  • Muscular Dystrophy
  • Muscular Dystrophy in Children
  • Vasodilation
  • Exercise
  • DMD

Interventions

  • TadalafilDrug

    Patients will be given either the intervention medication or a placebo (double-blinded, randomized trial) and will be asked to take the medication every day for 6 months in conjunction with weekly exercise sessions.

  • PlaceboDrug

    Patients will be given either the intervention medication or a placebo (double-blinded, randomized trial) and will be asked to take the medication every day for 6 months in conjunction with weekly exercise sessions.

  • Exercise TrainingOther

    The home-based cycling exercise training program is designed to improve muscle strength and endurance. Participants will engage in individualized exercise sessions up to four times per week, lasting up to 40 minutes each. Live video and heart rate monitoring will ensure proper exercise performance and allow for adjustments to the program throughout the study. The participants will receive the exercise equipment for use at home.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Vascular responsiveness after muscle contraction to a single dose of tadalafil.Time frame: up to 4 weeks after the completion of Visits 1 and 2 of Aim 1.
  2. Cycling time to fatigueTime frame: Baseline and 6 month follow-up visits of Aim 2.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Florida Clinical and Translational Research Building

    Gainesville, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.